Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Argus Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,946,853

« Back to Dashboard

Summary for Patent: 4,946,853

Title: Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
Abstract:A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous medium is formed by adding a given amount of nicotine to a solution of a solidifying or gel-forming agent or mixture thereon in a suitable solvent or mixture of solvents and mixing or heating the mixture thereby obtained so as to form the solid, semi-solid or mucilaginous medium. The preparation can be used in a method of treating withdrawal symptoms associated with smoking cessation and for combating the psychological dependence that occurs through frequency smoking.
Inventor(s): Bannon; Yvonne B. (Naas, IE), Corish; John (Leopardstown, IE), Corrigan; Owen I. (Howth, IE), Geoghegan; Edward J. (Athlone, IE), Masterson; Joseph G. (Dublin, IE)
Assignee: Elan Transdermal Limited (Athlone, IE)
Application Number:07/188,226
Patent Claim Types:
see list of patent claims
Formulation; Compound; Device; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,946,853

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Ireland1119/87May 01, 1987
Ireland1946/87Jul 17, 1987

International Patent Family for Patent: 4,946,853

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria161721► Subscribe
Australia1534988► Subscribe
Australia607214► Subscribe
Canada1333051► Subscribe
Germany3856096► Subscribe
Denmark235088► Subscribe
European Patent Office0289342► Subscribe
Spain2112241► Subscribe
Greece3026563► Subscribe
Ireland57786► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: